Obstetrical outcomes are unchanged after hysteroscopic myomectomy in women with submucosal fibroids

2020 ◽  
Vol 2 (4) ◽  
pp. 100192
Author(s):  
Yaneve N. Fonge ◽  
Ashlie S. Carter ◽  
Matthew K. Hoffman ◽  
Anthony C. Sciscione ◽  
Jordan Klebanoff
2021 ◽  
Vol 6 (2) ◽  
pp. 88-93
Author(s):  
Oana Denisa Balalau ◽  
◽  
Mihai-George Loghin ◽  
Sabin Vasilache ◽  
Octavian Gabriel Olaru ◽  
...  

Uterine leiomyomatosis is one of the most common benign pelvic tumors diagnosed in women aged 25-44 years. Clinically, it is manifested by vaginal bleeding, pelvic pain, infertility, digestive and urinary symptoms. The diagnosis of uterine fibroids requires careful clinical and paraclinical evaluation. Based on these data, the therapeutic decision is conducted in most cases. The treatment of uterine leiomyomatosis involves several procedures, such as: total abdominal hystectomy, total vaginal hystectomy, abdominal myomectomy, vaginal, laparoscopic or hysteroscopic myomectomy. Hysteroscopic myomectomy is currently the preferred procedure for submucosal fibroids. It has multiple advantages: shorter recovery time, reduced pain related to movements, shorter duration procedure and fewer risks. The procedure has few contraindications. The most common complication is recurrence. The treatment of choice for prolapsed pedunculated submucous leiomyoma is vaginal myomectomy. As described, the procedure has multiple advantages and generally has a low recurrence rate.


2020 ◽  
Author(s):  
Cinta Vidal Mazo

Submucosal fibroids account for 10% of total fibroids. They significantly impact quality of life causing abnormal uterine bleeding (AUB), reduction in fertility rates/infertility, obstetrics complications and abdominal pain. They are a major public health concern because of economic cost their monitoring and treatment requires. Hysteroscopic myomectomy is the first line minimally invasive and conservative surgical treatment. Treating a fibroid correctly implies knowing its physiopathology: What is a submucosal fibroids and what is its origin, what is the Pseudocapsule?. Proper diagnosis and standardized classification such as the Wamsteker classification are required. What are the limits to perform a hysteroscopic myomectomy? What devices are currently used? What are the requirements for conducting myomectomy procedures in the outpatient setting?. Different forms of surgical approach. Complications and consequences of a myomectomy. What will we do in the future with the management of small submucosal fibroids in asymptomatic patients with future genetic desires and can we resect type 3 fibroids by hysteroscopy avoiding a higher risk surgery by abdominal route?


2015 ◽  
Vol 22 (3) ◽  
pp. S62
Author(s):  
N. Mahnert ◽  
C. Lim ◽  
B. Skinner ◽  
E. Quint ◽  
S. As-Sanie

2017 ◽  
Vol 129 ◽  
pp. 8S
Author(s):  
Brian Liu ◽  
Michael Ordon ◽  
Janet Bodley ◽  
Grace Liu ◽  
Jamie Kroft
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document